EPHA2 and neoplasm: The most well-characterised example of this is for EphA2, where the classical ligand- and tyrosine kinase-dependent signalling mechanism is accompanied by a pathway in which tumour promotion is achieved independently of ligand or tyrosine kinase activation of the receptor [4].